Explore the full range of solutions Cognitime divisions provide:
Explore the full range of solutions Cognitime divisions provide:
Speed up value dossier creation by 55%. Our AI-powered solution automates the process to minimize manual input, reduce compliance risks, and convert complex reports into well-structured dossiers in record time.
Our automated data processing tools use ML to clean and harmonize data. Advanced analytics and causal inference draw accurate conclusions. The solution structures and analyzes complex datasets with 3x the speed. As a result, it provides faster insights into treatment outcomes while helping to reduce research costs.
Extract patient-reported outcomes from external sources 75% faster with NLP-driven tools. Analyze sentiment symptoms and unmet needs to improve trial design, boost engagement, and refine care strategies.
With GenAI, HEOR teams create models at 10x less cost. Trained GenAI models test different scenarios, write statistical code, handle complex calculations, and reduce submission errors. Over 73% of NLP-generated models are accurate on the first draft. Build cost-effective models in minutes, not days.
More solutions
Our platforms interpret trends and policy shifts to support market access planning in hours instead of weeks. The model unifies data sources and automates complex analysis. ML uncovers pricing-relevant patterns while NLP helps query market data. The solution also cuts forecasting errors by up to 23%.
Accelerate drug discovery and clinical development with deep learning. The solution predicts promising candidates, reduces lab testing, and eases patient recruitment. We help pharma companies bring treatments to market up to 40% faster while cutting R&D costs.
In the solution, NLP and ML automate case intake, triage, and data entry. The system uses OCR to extract key information from source documents. RPA helps enter data into a safety system. The solution reduces case processing time by 60% and brings up to 44% in cost savings.
Improve real-world outcomes research with AI-powered disease activity tracking and 100% data usability. The models extract structured data from clinical notes with 96% accuracy to fill evidence gaps. They also improve measurement accuracy and support personalized care strategies across diverse patient populations.
Identify eligible patients for targeted therapies with up to 15x higher precision using AI-powered real-world data analysis. The models detect complex diagnostic patterns and match patients to providers. As a result, you get faster treatment uptake and improved therapy outcomes.
Forecast regulatory and reimbursement decisions with AI models trained on past HTA data. Our solutions help you simulate outcomes, adjust strategies in advance, and improve the predictability of your market access planning with up to 90% accuracy.
